News Curated �鶹��ý Channel: Medical Meetings

International Cancer Organizations Present Collaborative Work During Oncology Event in China

National Comprehensive Cancer Network(r) (NCCN(r)) — Fri, 15 Nov 2024 09:05:07 EST

The National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.

Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip Sheet

Sylvester Comprehensive Cancer Center — Wed, 13 Nov 2024 13:25:18 EST

Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami will be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, Dec. 7-10.

Smidt Heart Institute Experts Will Give Key Presentations at AHA Scientific Sessions 2024

Cedars-Sinai — Tue, 12 Nov 2024 15:40:10 EST

Physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will give more than 30 presentations at the American Heart Association (AHA) Scientific Sessions Nov. 16-18 in Chicago.

Hackensack University Medical Center to Hold Annual Diabetes Awareness Month Event

Hackensack Meridian Health — Tue, 12 Nov 2024 12:45:40 EST

Cleveland Clinic Announces Updated Findings in Preventive Breast Cancer Vaccine Study

Cleveland Clinic — Fri, 08 Nov 2024 10:25:35 EST

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. The study team found that the investigational vaccine was generally well tolerated and produced an immune response in most patients. The team described the side effects of the vaccine, showed the highest tolerated dose to date, and presented the immunologic effects of the vaccine. Findings are being presented at the Society for Immunotherapy of Cancer Annual Meeting.

Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024

Cedars-Sinai — Thu, 07 Nov 2024 17:30:56 EST

Experts on healthy aging from Cedars-Sinai's growing Center for Translational Geroscience and Geriatrics Program will present their latest research and clinical advances at The Gerontological Society of America's (GSA) 2024 Annual Scientific Meeting in Seattle, Nov. 13-16.

Stephen Wolfram presents at the American Academy of Arts and Sciences for the Hertz Foundation's Empowering Excellence Event

The Fannie and John Hertz Foundation — Tue, 05 Nov 2024 16:55:44 EST

The Hertz Foundation and the American Academy of Arts and Sciences (AAAS) have jointly released a keynote talk, Where the Computational Paradigm Leads (in Physics, Tech, AI, Biology, Math, ...), by visionary mathematician Stephen Wolfram, delivered to members of the Hertz Foundation board of directors and invited guests at the Empowering Excellence: The Hertz Way event held October 18 at the American Academy of Arts and Sciences headquarters in Cambridge, Massachusetts.

Hackensack Meridian JFK Johnson Rehabilitation Institute: Leading the Way in PM&R Innovation at AAPMR 2024

Hackensack Meridian Health — Mon, 04 Nov 2024 11:00:29 EST

Hackensack Meridian JFK Johnson Rehabilitation Institute, a nationally recognized leader in physical medicine and rehabilitation, is proud to announce its participation in the upcoming American Academy of Physical Medicine And Rehabilitation Annual Assembly (AAPMR) 2024 Annual Assembly, taking place November 6-10 in San Diego, CA.

Research Shows New Method Helps Doctors Safely Remove Dangerous Heart Infections Without Surgery

Mayo Clinic — Wed, 30 Oct 2024 14:45:46 EST

Doctors at Mayo Clinic used a new catheter-based approach to draw out resistant pockets of infection that settle in the heart, known as right-sided infective endocarditis, without surgery. Unless treated quickly, the walled-off infections can grow, severely damaging heart valves and potentially affecting other organs as well. In a recent study, over 90% of the participants had their infection cleared, and they had lower in-hospital mortality compared to those whose infections remained.

Routine Colchicine Administration After Acute Myocardial Infarction Does Not Improve Outcomes

Cardiovascular Research Foundation (CRF) — Wed, 30 Oct 2024 11:55:05 EST

The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization.

Orbital Atherectomy Prior to Coronary Stent Implantation Does Not Lead to Better Outcomes Compared to Conventional Balloon Angioplasty

Cardiovascular Research Foundation (CRF) — Wed, 30 Oct 2024 11:05:34 EST

Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary arteries.

Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds

Mount Sinai Health System — Tue, 29 Oct 2024 11:00:13 EST

First-of-its kind work led by Mount Sinai researcher supports reserving this technique for extreme cases

Kidney Week 2024: Virtual Press Briefings

News — Mon, 28 Oct 2024 10:05:21 EST

Kidney Week 2024: Live Event

Prabir Roy-Chaudhury, MD, PhD, FASN, to Become Next President of the American Society of Nephrology

American Society of Nephrology (ASN) — Sun, 27 Oct 2024 12:00:00 EST

Dr. Roy-Chaudhury will head up an organization--with nearly 21,000 health professionals representing 140 countries--dedicated to leading the fight against kidney diseases.

James Tracy Installed as ACAAI President

American College of Allergy, Asthma and Immunology (ACAAI) — Sun, 27 Oct 2024 08:00:00 EST

Allergist James Tracy, DO, of Omaha, NE, was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the ACAAI Annual Scientific Meeting on October 27 in Boston. Allergist Cherie Zachary, MD, of Eagan, MN, was elected ACAAI president-elect.

James Tracy Es Nombrado Presidente Del ACAAI

American College of Allergy, Asthma and Immunology (ACAAI) — Sun, 27 Oct 2024 08:00:00 EST

El alergista James Tracy, DO (Doctor en Medicina Osteopatica), de Omaha, NE, fue instalado como presidente del Colegio Americano de Alergia, Asma e Inmunologia (ACAAI) en la Reunion Cientifica Anual del ACAAI el 27 de octubre en Boston. La alergista Cherie Zachary, MD, de Eagan, Minnesota, fue elegida presidenta electa del ACAAI.

Researchers Test Imlifidase Enzyme Versus Plasma Exchange in Removing Donor-Specific Antibodies in Kidney Transplant Rejection Trial

American Society of Nephrology (ASN) — Sat, 26 Oct 2024 19:30:00 EST

For kidney transplant recipients experiencing antibody-mediated rejection, the current standard of care involves removing donor-specific antibodies (DSAs) through plasmapheresis (PLEX)--a procedure that removes antibodies from the plasma portion of the blood. Results from a recent clinical trial reveal that an investigational drug called imlifidase, which cleaves and inactivates the type of antibodies that include DSAs, is more effective than PLEX. The research will be presented at ASN Kidney Week 2024 October 23-27.

Preclinical Studies Test Novel Gene Therapy for Treating IgA Nephropathy

American Society of Nephrology (ASN) — Sat, 26 Oct 2024 19:30:00 EST

IgA nephropathy is an autoimmune kidney disease, and complement, a component of the innate immune system, plays a role in the condition's pathogenesis. Investigators have developed and tested a novel gene therapy that enters kidney cells and enables them to block complement activation. The research will be presented at ASN Kidney Week 2024 October 23- 27.

Trial Assesses Antibody Therapy for Chronic Active Antibody-Mediated Kidney Transplant Rejection

American Society of Nephrology (ASN) — Sat, 26 Oct 2024 19:30:00 EST

Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the inflammatory cytokine interleukin-6 (IL-6), stabilized kidney transplant recipients' kidney function in a phase 2 trial. Investigators now have data from a phase 3 trial with clazakizumab. The findings from the Phase 3 IMAGINE trial, the largest placebo-controlled study in kidney transplant recipients with caAMR, will be presented at ASN Kidney Week 2024 October 23- 27.

High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health: Part 2

American Society of Nephrology (ASN) — Sat, 26 Oct 2024 13:30:00 EST

The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2024 October 23-27.